Concepedia

Ana Tadijan

AT

Statistics

Publications

4

Citations

87

H-Index

4

Active since

2021

Affiliations

Ruđer Bošković Institute(Current)

Ana Tadijan is an author at Ruđer Bošković Institute specializing in oncology, cell signaling, and cancer progression.

ORCID

Publications per year

2021–2022

4

Publications

4

Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness

Ana Tadijan, Francesca Precazzini, Nikolina Hanžić et al. · Cancers · 2021 · 34 citations · Full text

, , +16

Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance

Martina Radić, Ignacija Vlašić, Maja Jazvinšćak Jembrek et al. · International Journal of Molecular Sciences · 2022 · 21 citations · Full text

, , +17

The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity

Ana Tadijan, Jonathan D. Humphries, Ivana Samaržija et al. · Frontiers in Cell and Developmental Biology · 2021 · 19 citations · Full text

, , +17

Chronic High Fat Diet Intake Impairs Hepatic Metabolic Parameters in Ovariectomized Sirt3 KO Mice

Marija Pinterić, Iva I. Podgorski, Marijana Popović Hadžija et al. · International Journal of Molecular Sciences · 2021 · 13 citations · Full text

, , +17

1–4 of 4